Alcmeón – Revista Argentina de Clínica Neuropsiquiátrica – Sobre la vejez, el corazón y el cerebro

“Guidelines for the management of transient ischemic attacks”. Circulation Vol 89 No 6 Jun 1994.

“National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. (JNC V). “Hypertension Vol 23 No 3 Mar 1994.

“Prevention of Stroke by Antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP)“. JAMA, June 26, 1991-Vol 265 No 24.

“The Sixth report of the joint National Committee and detection, evaluation and treatment of high blood Pressure (JNC VI)

” Arch Int Med 1997.

Asakura, Sato. Lipoprotein disorder in brain infarction and hemorrhage. Int.J.Clin.Lab. Res. 1998;28(1):39-46.

Collen D, Holvoet P. Thrombosis and atherosclerosis. Curr. Opin. Lipidol. 1997 Oct;8(5):320-8.

Dahlof, B., and col. “Morbility and mortality in Stop Hypertension”. Lancet 1991: Vol 338 Pg 1281-1285.

Duke, RC., Ojcius, DM., Ding-E-Young, J. “Celular Suicide, in the health and the disease“. Scientific American No 245 Feb 1997

Dzau, V., and Gibbons, GH., “The emerging concept of vascular remodelling.” New Eng.J.Med. Vol 330 No 20 1994.

Ford D, Mead L, et al. Depression is a risk factor for coronary artery disease in men. Arch Intern Med. 1998 Jul; 158:14221426

Furchegott, R., Zawadzki,J., “The obligatory role of endothelial cell in the relaxation of arterial smooth muscle by acetylcholine“. Nature Vol 228 No 27 1980.

Fuster Valentin, MD, PhD. Progression-regression of atherogenesis: molecular, cellular, and clinical bases. Circulation Suppl. Vol.86 Nro.6 December 1992.

Gibbons, GH., “Endothelial function as a determinant of vascular function and structure: a new therapeutic target“. Am.J.Cardiol. 1997; 79: (5 A): 3-8.

Hennekens, MD, and col. “Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease“. Circulation 1989; 80: 749-756.

Kannel, NB., Dawber, TR., “American epidemiologic study of heart disease.” The Framingham Study 16; 1: Jun 1958.

Kaplan, NM., MD. “Clinical Hypertension“. 6th Edition. Williams & Wilkins 1994.

Kerr, FR., Wyllie, AH., Currie, AR., “Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kinetics“. British.Journal of cancer Vol 26 239-257: 1972.

Moncada, S., “The L-arginine-nitric oxide pathway“. New Eng.J.Med. Vol 239 No 27 1993.

Moncada, S., and Lopéz-Jaramillo, P. “The Biological activity in the vascular endothelium“. Scientific American. Vol 176 Pg 60 1991.

Moncada, S., and Palmieri, RM., “Nitric oxide release account for the biological activity of endothelium-derived relaxing factor“. Nature Vol 327 No 11 1987.

Palmer, RM., and Moncada, S., “Vascular endothelial cell synthesize nitric oxide from L-arginine“. Nature Vol 333 No 16 1988.

Rusting, RL,” Why do we get older?” Scientific American No 197 Feb 1993.

Ruth SoRelle. “Nobel Prize awarded to scientists for nitric oxide discoveries”. Circulation 1998; 98:2365-2366.

Snyder, SH., Bredt, DS., “Biological function of the nitric oxide“. Scientific American 1992.

Spence, JD. “Cerebral consequences of hypertension: where do they lead?” Journal of Hypertension 1996, 14(suppl 5): S139-S145.

Yanagisawa, M., and col. “A novel potent vasoconstrictor peptide produced by vascular endothelium cells“. Nature Vol 332 No 31 1988.